Testing Canada’s New Pharmaceutical Transparency Law

Matthew Herder and Trudo Lemmens explore the ways that Canada’s transparency legislation may limit researchers’ abilities to scrutinize drug safety and effectiveness.

Pharma Financialized

Matthew Herder argues that recent drug price hikes are only one part of a bigger problem with industry-driven pharmaceutical research and development.

Statement Against Misogyny and Gendered Violence

The Opacity of Bill C-17’s Transparency Amendments

Matthew Herder says it is unclear whether the ‘Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)’ will provide greater transparency in Canadian drug regulation.

Seeking Accountability From CIHR for its Failed Decision-Making

Canadian health ethics researchers request action on problems at CIHR in letter to members of the Canadian Parliament and Senate.